Zoetis Inc. ZTS revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Zoetis Inc. reported revenue across 20 products and services; the largest, Total Productsand Services, was $9.35B (+1.9% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Total Productsand Services$9.35Bshare n/a+1.9% yoy
- Companion Animal$6.59Bshare n/a+4.9% yoy
- Horses$6.28Bshare n/a+4.8% yoy
- Livestock$2.76Bshare n/a-4.6% yoy
- Parasiticides$2.34Bshare n/a+8.7% yoy
- Vaccines$1.96Bshare n/a+7.2% yoy
- Dermatology$1.75Bshare n/a+6.0% yoy
- Cattle$1.49Bshare n/a-2.5% yoy
- +12 more members in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Total Geographical Area$9.35Bshare n/a+1.9% yoy
- United States$5.1Bshare n/a+0.5% yoy
- Other Emerging Markets$913Mshare n/a+5.5% yoy
- Other Developed Markets$641Mshare n/a+13.7% yoy
- Brazil$393Mshare n/a-5.1% yoy
- Australia$329Mshare n/a+3.1% yoy
- United Kingdom$325Mshare n/a+3.5% yoy
- Canada$290Mshare n/a+4.7% yoy
- +8 more members in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Total Productsand Services$2.24Bshare n/a+3.3% yoy
- Companion Animal$1.52Bshare n/a-1.4% yoy
- Dogs And Cats$1.44Bshare n/a-2.3% yoy
- Livestock$720Mshare n/a+14.8% yoy
- Parasiticides$586Mshare n/a+2.4% yoy
- Vaccines$519Mshare n/a+18.2% yoy
- +13 more members in the filing
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.